Document Detail


Alterations in myocardial uptake of glutamate and release of alanine after propranolol, nifedipine, and glyceryl trinitrate in coronary artery disease.
MedLine Citation:
PMID:  2581096     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We examined the effects of antianginal drugs on myocardial uptake of glutamate and release of alanine in patients with chronic effort angina. Thirty-three patients underwent two periods of atrial pacing, the second preceded either by no medication (controls) (n = 8), 0.1 mg/kg i.v. propranolol (n = 8), 30 mg nifedipine sublingually (n = 9) or 0.75 mg glyceryl trinitrate sublingually (n = 8). Before, during, and after each pacing period, coronary sinus blood flow (CSBF), oxygen uptake, and arteriocoronary sinus differences (ACs) of plasma glutamate and alanine were determined. In all groups of patients, arterial alanine concentration fell during the second test. Except for this fall, no metabolic change was seen in controls. Propranolol increased circulating arterial concentration and ACs values of glutamate throughout the test. Nifedipine did not change arterial glutamate concentration but decreased ACs glutamate before and after pacing. Glyceryl trinitrate decreased CSBF, oxygen uptake, and net myocardial uptake of glutamate before pacing despite unchanged arterial level and ACs values. Alterations of myocardial glutamate uptake after drugs may reflect metabolic effects of propranolol primarily exerted on extracardial sites and of nifedipine exerted on the myocardium itself, whereas changes after glyceryl trinitrate seem to be secondary to its cardiac unloading effect. Alterations in myocardial release of alanine were too small and inconsistent to be taken as drug effects.
Authors:
A Thomassen; T T Nielsen; J P Bagger
Related Documents :
9495866 - The enantiomer-specific kinetics and dynamics of verapamil after rapid intravenous admi...
21807426 - Accentuated left ventricular lateral wall function compensates for septal dyssynchrony ...
3903736 - Beta-blocker heart attack trial: impact of propranolol therapy on ventricular arrhythmias.
727146 - Superiority of practolol versus propranolol in protection against ventricular fibrillat...
3946176 - Left ventricular bands (false tendons): echocardiographic and angiocardiographic deline...
11678386 - Dispersion of atrial repolarization in patients with paroxysmal atrial fibrillation.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  7     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:    1985 Mar-Apr
Date Detail:
Created Date:  1985-06-18     Completed Date:  1985-06-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  394-400     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Alanine / secretion
Blood Pressure / drug effects
Coronary Disease / metabolism*
Female
Glutamates / metabolism
Glutamic Acid
Heart Rate / drug effects
Humans
Male
Middle Aged
Myocardium / metabolism*
Nifedipine / pharmacology*
Nitroglycerin / pharmacology*
Propranolol / pharmacology*
Chemical
Reg. No./Substance:
0/Glutamates; 21829-25-4/Nifedipine; 525-66-6/Propranolol; 55-63-0/Nitroglycerin; 56-41-7/Alanine; 56-86-0/Glutamic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Disopyramide and quinidine bind with inverse selectivity to muscarinic receptors in cardiac and extr...
Next Document:  Alpha 1- and alpha 2-adrenoceptor-mediated pressor responses: are they differentiated by calcium ant...